Literature DB >> 31468462

Anti-inflammatory Action of Glucose-Taurine Reduced by Inhibiting NF-κB Activation in LPS-Activated RAW264.7 Macrophages.

Hwan Lee1, Dong-Sung Lee1, Kyung Ja Chang2, Sung Hoon Kim3, Sun Hee Cheong4.   

Abstract

In the present study, we investigated the regulation of inflammatory effects by glucose-taurine reduced (G-T-R), a taurine-carbohydrate derivative, on lipopolysaccharide (LPS)-induced RAW264.7 macrophages. The anti-inflammatory action of G-T-R revealed that this derivative markedly inhibited the nitric oxide (NO) and prostaglandin E2 (PGE2) production in RAW264.7 macrophages induced by LPS. Suppression of NO and PGE2 production was involved in the inhibitory action by G-T-R on the inducible nitric oxide synthase and cyclooxygenase-2 proteins expression. G-T-R decreased the production of a variety of pro-inflammatory cytokines, including tumor necrosis factor-α, interleukin-1β, and interleukin-6. Moreover, G-T-R effectively suppressed the nuclear factor-kappa B (NF-κB) activation in LPS-stimulated RAW264.7 macrophages according to evaluation of the molecular inflammatory mechanisms. Thus, we suggest that G-T-R modulates several inflammatory pathways mediated by NF-κB activation, demonstrating its potential or preventing and treating inflammatory conditions.

Entities:  

Keywords:  Anti-inflammatory; Glucose-taurine reduced; Lipopolysaccharide; Nuclear factor-κB activation; RAW264.7 macrophages

Mesh:

Substances:

Year:  2019        PMID: 31468462     DOI: 10.1007/978-981-13-8023-5_82

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  1 in total

1.  Neuroprotective Effect of Taurine against Cell Death, Glial Changes, and Neuronal Loss in the Cerebellum of Rats Exposed to Chronic-Recurrent Neuroinflammation Induced by LPS.

Authors:  Samara P Silva; Adriana M Zago; Fabiano B Carvalho; Lucas Germann; Gabriela de M Colombo; Francine L Rahmeier; Jessié M Gutierres; Cristina R Reschke; Margarete D Bagatini; Charles E Assmann; Marilda da C Fernandes
Journal:  J Immunol Res       Date:  2021-07-05       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.